A surge of diphtheria cases in Australia, driven by a perfect storm of antibiotic resistance and climate-fuelled population displacement, has triggered a formal review of UK vaccination schedules. The pathogen, once considered a relic of Victorian medicine, is demonstrating a disturbing adaptability that parallels the systemic stresses we now see across multiple biospheres.
Diphtheria, caused by *Corynebacterium diphtheriae*, had been effectively suppressed in high-income nations through rigorous childhood immunisation. Australia recorded only a handful of cases annually until 2022. Then the curve steepened. In 2023, over 40 cases were confirmed, concentrated among indigenous communities in Queensland and the Northern Territory. This is not a statistical blip; it is a canary in the coal mine.
The causative factors are layered. First, we see the predictable consequence of waning vaccine coverage. Australia’s childhood immunisation rate for diphtheria has slipped below 90% in some regions, driven by logistical challenges in remote areas and an insidious rise in vaccine hesitancy. But the more concerning variable is the emergence of multidrug-resistant strains. A 2024 genomic surveillance study published in the *Lancet Microbe* identified isolates carrying genes conferring resistance to erythromycin and azithromycin, the first-line treatments. This is not merely a clinical inconvenience. It represents a fundamental shift in the pathogen’s evolutionary trajectory, accelerated by the selective pressure of overused antibiotics in both human and animal populations.
Climate change amplifies this danger. Rising temperatures and extreme weather events in Australia have disrupted healthcare infrastructure and forced population movements. Overcrowded temporary housing, poor sanitation, and reduced cold-chain capacity for vaccine transport create perfect conditions for respiratory droplet transmission. As the planet warms, the geographic range of diphtheria vectors and carriers may expand, much as we have seen with dengue and Lyme disease. The pathogen does not respect borders. A case in Sydney today can become a cluster in Manchester tomorrow via a single international flight.
British health officials are right to act. The UK Health Security Agency has announced a review of the current vaccination protocol, which includes a five-dose schedule through childhood. The concern is not only about imported cases. Vaccine coverage in the UK has also declined slightly, with some London boroughs falling below 85% for the preschool booster. In an era of globalised travel and climate-driven migration, a pathogen’s local re-establishment becomes probable once the susceptible population reaches a critical threshold. The R0 for diphtheria is estimated between 6 and 7, comparable to measles. We only need to look at the recent measles outbreaks in the UK to see the pattern.
The broader implication is one of systemic vulnerability. Our public health infrastructure, designed in a more stable climate, is now being stress-tested by variables we have not adequately modelled. Antibiotic resistance and climate change are not separate crises. They are coupled feedback loops. Warmer temperatures accelerate bacterial replication and horizontal gene transfer. Droughts and floods reduce access to clean water and healthcare. Malnutrition worsens immune response. Each factor multiplies the others.
There is a technical solution: revaccination campaigns, improved surveillance, and the development of next-generation antibiotics and vaccines. But these require political will and sustained investment. The UK’s review is a necessary first step, but it must be matched by global action. We cannot treat diphtheria as a localised anomaly. It is a symptom of a biosphere in decline, a signal that our systems of protection are fraying. The calm urgency of this moment demands that we listen.
